346 related articles for article (PubMed ID: 3159806)
1. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
Sontheimer RD
J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
[TBL] [Abstract][Full Text] [Related]
2. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
[TBL] [Abstract][Full Text] [Related]
3. The autologous mixed epidermal cell-T lymphocyte reaction is elevated in psoriasis: a crucial role for epidermal HLA-DR+/CD1a- antigen-presenting cells.
Prens EP; Benne K; van Joost T; Benner R
J Invest Dermatol; 1991 Jun; 96(6):880-7. PubMed ID: 1710638
[TBL] [Abstract][Full Text] [Related]
4. T-cell response to purified protein derivative after removal of Langerhans' cells from epidermal cell suspensions containing keratinocytes expressing class II transplantation antigens.
Tjernlund U; Scheynius A; Johansson C; Hagforsen E; Nilsson H
Scand J Immunol; 1988 Dec; 28(6):667-73. PubMed ID: 3266023
[TBL] [Abstract][Full Text] [Related]
5. Hyperstimulatory CD1a+CD1b+CD36+ Langerhans cells are responsible for increased autologous T lymphocyte reactivity to lesional epidermal cells of patients with atopic dermatitis.
Taylor RS; Baadsgaard O; Hammerberg C; Cooper KD
J Immunol; 1991 Dec; 147(11):3794-802. PubMed ID: 1719088
[TBL] [Abstract][Full Text] [Related]
6. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
Czernielewski JM; Schmitt D; Faure MR; Thivolet J
Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
[TBL] [Abstract][Full Text] [Related]
7. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
Ashworth J; Kahan MC; Breathnach SM
Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
[TBL] [Abstract][Full Text] [Related]
8. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
Cooper KD; Neises GR; Katz SI
J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
[TBL] [Abstract][Full Text] [Related]
9. Antigen-presenting cells in essential fatty acid-deficient murine epidermis: keratinocytes bearing class II (Ia) antigens may potentiate the accessory cell function of Langerhans cells.
Udey MC; Peck RD; Pentland AP; Schreiner GF; Lefkowith JB
J Invest Dermatol; 1991 Jun; 96(6):950-8. PubMed ID: 1828477
[TBL] [Abstract][Full Text] [Related]
10. Amplification of T-cell response to PPD by epidermal cell suspensions containing HLA-DR-expressing keratinocytes.
Tjernlund U; Scheynius A
Scand J Immunol; 1987 Jul; 26(1):1-6. PubMed ID: 2441455
[TBL] [Abstract][Full Text] [Related]
11. Human epidermal cell-induced generation of alloreactive cytotoxic T-lymphocyte responses against epidermal cells. Requirement for DR-positive Langerhans cells.
Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J
Scand J Immunol; 1985 May; 21(5):441-6. PubMed ID: 3159078
[TBL] [Abstract][Full Text] [Related]
12. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J
Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation.
Meunier L; Bohjanen K; Voorhees JJ; Cooper KD
J Invest Dermatol; 1994 Dec; 103(6):775-9. PubMed ID: 7798614
[TBL] [Abstract][Full Text] [Related]
14. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
Thorsby E; Berle E; Scott H; Braathen LR
Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
[TBL] [Abstract][Full Text] [Related]
15. Mixed epidermal cell lymphocyte reaction: HLA-DR+ cells exhibit a greater immunostimulatory activity than CD1a+ cells.
Dobmeyer TS; Dobmeyer JM; Klein SA; Schopf RE; Helm EB; Rossol R
Adv Exp Med Biol; 1995; 378():393-6. PubMed ID: 8526102
[No Abstract] [Full Text] [Related]
16. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
Braathen LR; Thorsby E
Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
[TBL] [Abstract][Full Text] [Related]
17. Alveolar macrophage stimulation of T-cell proliferation in autologous mixed lymphocyte reactions. Role of HLA-DR antigens.
Rossi GA; Zocchi E; Sacco O; Balbi B; Ravazzoni C; Damiani G
Am Rev Respir Dis; 1986 Jan; 133(1):78-82. PubMed ID: 2935058
[TBL] [Abstract][Full Text] [Related]
18. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells.
Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J
Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919
[TBL] [Abstract][Full Text] [Related]
19. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell induced cytotoxic T-cell responses against normal human epidermal cell targets: in vitro studies.
Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J
Br J Dermatol; 1985 Jul; 113 Suppl 28():114-7. PubMed ID: 3160381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
